Bleichroeder LP’s Cue Biopharma CUE Stock Holding History

Bleichroeder LP’s Portfolio CUE Stock Details CUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.7M	Buy	370,682 +143,377	+63%	+$3.24M	2.09%	8
2026 Q1	$1.57M	Hold	227,305	–	–	0.27%	34
2025 Q4	$2.08M	Hold	227,305	–	–	0.37%	28
2025 Q3	$4.9M	Hold	227,305	–	–	0.96%	14
2025 Q2	$4.65M	Buy	227,305 +60,730	+36%	+$1.3M	1.14%	14
2025 Q1	$4.55M	Hold	166,575	–	–	1.21%	14
2024 Q4	$5.45M	Hold	166,575	–	–	1.37%	14
2024 Q3	$3.78M	Buy	166,575 +71,188	+75%	+$1.54M	1.02%	13
2024 Q2	$3.55M	Buy	95,387 +3,553	+4%	+$176K	1.06%	17
2024 Q1	$5.21M	Buy	91,834 +33,333	+57%	+$2.35M	1.3%	18
2023 Q4	$4.63M	Buy	58,501 +33,333	+132%	+$2.38M	1.03%	16
2023 Q3	$1.74M	Hold	25,168	–	–	0.43%	24
2023 Q2	$2.76M	Hold	25,168	–	–	0.56%	25
2023 Q1	$2.7M	Sell	25,168 -3,541	-12%	-$338K	0.58%	23
2022 Q4	$2.45M	Buy	28,709 +10,209	+55%	+$934K	0.53%	27
2022 Q3	$1.24M	Hold	18,500	–	–	0.26%	36
2022 Q2	$1.38M	Buy	18,500 +100	+0.5%	+$11.7K	0.29%	36
2022 Q1	$2.69M	Buy	18,400 +11,733	+176%	+$2.49M	0.48%	34
2021 Q4	$2.26M	Buy	6,667 +834	+14%	+$323K	0.35%	42
2021 Q3	$2.55M	Hold	5,833	–	–	0.41%	41
2021 Q2	$2.04M	Buy	5,833 +3,333	+133%	+$1.29M	0.31%	44
2021 Q1	$915K	Hold	2,500	–	–	0.15%	47
2020 Q4	$938K	Sell	2,500 -2,500	-50%	-$999K	0.18%	42
2020 Q3	$2.26M	Sell	5,000 -500	-9%	-$288K	0.4%	35
2020 Q2	$4.04M	Hold	5,500	–	–	0.72%	27
2020 Q1	$2.34M	Hold	5,500	–	–	0.61%	29
2019 Q4	$2.62M	Buy	+5,500	New	+$1.73M	0.41%	27

Other funds holding CUE

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

TAM

TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return

Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

LPC

Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $322M AUM

Diadema Partners Morristown, New Jersey $791M AUM 245.83% 1-Year Est. Return

Bleichroeder LP's CUE Position: Q2 2026 in Review

Bleichroeder LP increased its Cue Biopharma (CUE) stake by 63% in Q2 2026, buying an estimated $3.24M and bringing the position to 370,682 shares worth $11.7M. The position accounts for 2.09% of the portfolio, ranked #8.

Bleichroeder LP first reported a position in CUE in Q4 2019 and has held it in 27 quarters since. 49 funds tracked by Wall St. Rank hold CUE as of Q2 2026.

Bleichroeder LP held 370,682 shares of Cue Biopharma worth $11.7M as of Q2 2026.
Bleichroeder LP bought 143,377 Cue Biopharma shares in Q2 2026, an estimated $3.24M.
Cue Biopharma made up 2.09% of Bleichroeder LP's portfolio in Q2 2026, its #8 holding.
Bleichroeder LP first reported a position in Cue Biopharma in Q4 2019 and has held it in 27 quarters since.
49 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2026.

Based on Bleichroeder LP's 13F filing for Q2 2026, filed 13 Aug 2026.